United Therapeutics (UTHR) Misses Q3 EPS by 14c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $475.45 +0.69%
Revenue Growth %: -1.2%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: -1.2%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $6.39, $0.14 worse than the analyst estimate of $6.53. Revenue for the quarter came in at $748.9 million versus the consensus estimate of $722.95 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
- Future Money Acquisition gets Nasdaq notice over late 10-Q filing
- Northrop Grumman wins $143M in new U.S. defense contracts
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
